These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8545444)

  • 1. Dissociation of galaninergic and neurotrophic plasticity in Down syndrome and Alzheimer disease.
    Mufson EJ; Benzing WC; Kordower JH
    Prog Clin Biol Res; 1995; 393():105-22. PubMed ID: 8545444
    [No Abstract]   [Full Text] [Related]  

  • 2. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins.
    Matsubara E; Sekijima Y; Tokuda T; Urakami K; Amari M; Shizuka-Ikeda M; Tomidokoro Y; Ikeda M; Kawarabayashi T; Harigaya Y; Ikeda S; Murakami T; Abe K; Otomo E; Hirai S; Frangione B; Ghiso J; Shoji M
    Neurobiol Aging; 2004 Aug; 25(7):833-41. PubMed ID: 15212837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophins and dementia--keeping in touch.
    Castrén E; Tanila H
    Neuron; 2006 Jul; 51(1):1-3. PubMed ID: 16815323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
    Mufson EJ; Counts SE; Perez SE; Binder L
    Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptides and senile dementia: focus on galanin.
    Valenti G; Ceresini G
    Funct Neurol; 1997; 12(3-4):181-6. PubMed ID: 9218974
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in plasticity and development: Language in atypical children.
    Reilly JS; Wulfeck BB
    Brain Lang; 2004 Feb; 88(2):163-6. PubMed ID: 14965538
    [No Abstract]   [Full Text] [Related]  

  • 11. The neurology of Alzheimer disease in Down syndrome.
    Lott IT
    Prog Clin Biol Res; 1992; 379():1-14. PubMed ID: 1409738
    [No Abstract]   [Full Text] [Related]  

  • 12. Down syndrome and Alzheimer's disease: a link between development and aging.
    Lott IT; Head E
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cuban epidemic optic myeloneuropathy: discrepancies regarding its possibly viral aetiology].
    Calzada-Sierra DJ; Tellería-Díaz A
    Rev Neurol; 2001 Oct 16-31; 33(8):798-800. PubMed ID: 11784979
    [No Abstract]   [Full Text] [Related]  

  • 14. Body temperature as a risk factor for Alzheimer's disease.
    Holtzman A; Simon EW
    Med Hypotheses; 2000 Nov; 55(5):440-4. PubMed ID: 11058425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histopathology of neuronal degeneration and plasticity in Alzheimer disease.
    Kowall NW; McKee AC
    Adv Neurol; 1993; 59():5-33. PubMed ID: 8420123
    [No Abstract]   [Full Text] [Related]  

  • 16. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
    Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProNGF, sortilin, and age-related neurodegeneration.
    Al-Shawi R; Hafner A; Chun S; Raza S; Crutcher K; Thrasivoulou C; Simons P; Cowen T
    Ann N Y Acad Sci; 2007 Nov; 1119():208-15. PubMed ID: 18056969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin in Alzheimer disease.
    Counts SE; Perez SE; Ginsberg SD; De Lacalle S; Mufson EJ
    Mol Interv; 2003 May; 3(3):137-56. PubMed ID: 14993421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related impairments of synaptic plasticity in the lateral perforant path input to the dentate gyrus of galanin overexpressing mice.
    Zheng K; Kuteeva E; Xia S; Bartfai T; Hökfelt T; Xu ZQ
    Neuropeptides; 2005 Jun; 39(3):259-67. PubMed ID: 15944020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.